The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions. - Wikidata - wikimedia - TriplyDB

The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions.

The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions.

http://www.wikidata.org/entity/Q36831902

about

The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation A comparison of adverse reaction rates for PAS C versus plasma platelet units.Cost-utility and budget impact of methylene blue-treated plasma compared to quarantine plasma.Costs and benefits of PAS platelets: a mix of science, quality, and value.Establishing a framework: economic evaluations in transfusion medicine, part 2.Evaluation of in vitro storage properties of apheresis platelets suspended in a bicarbonate-containing additive solution with low levels of plasma and stored with a 24-hour interruption of agitation.Direct costs of transfusion reactions - an expert judgement approach.In vitro variables of buffy coat-derived platelet concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions.Platelet Additive Solutions: A Review of the Latest Developments and Their Clinical Implications.

P2860

Q33632538-FEB07BAD-8524-403D-9DA2-C294FAC518E3 Q36187323-D4A796DC-7969-46B3-A21B-F0C1D5BD759A Q38204784-9C80FE3F-44C1-4839-BC1C-E296D6897B2C Q39148796-EB76B35C-881C-4533-AE57-433E6A257D41 Q44553130-599CD76D-5F7F-4F41-91D1-441A19F38221 Q45006373-774CAC2E-8CB9-4D40-B97F-DE9787E4A9A0 Q45391252-B05CAE41-5975-40DE-86D5-AF7D7C32EE27 Q47619489-DEA1408E-830D-4BC5-A4AA-6600F34B797D Q50451821-53C57123-0478-4E80-9755-BAEC0858AC49 Q55032481-F58C6B40-5190-46A9-8F98-1BA2B0E874F8

P2860

The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions.

http://www.wikidata.org/entity/Q36831902

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

The cost-effectiveness of plat ...... llergic transfusion reactions.

@en

type

label

The cost-effectiveness of plat ...... llergic transfusion reactions.

@en

prefLabel

The cost-effectiveness of plat ...... llergic transfusion reactions.

@en

P1433

Q36831902-C50045C0-5FE4-4ADC-B897-4FFB79B630D2

P1476

Q36831902-176F16F6-1305-4A1D-AD32-2D406B8178B8

P2093

Q36831902-2AC3B70C-82EA-44AF-BD22-AF11BF30399C

Q36831902-3765A17D-8655-407C-B490-57470939238B

Q36831902-52989923-D1FC-4288-84CB-6ED2010D8D94

Q36831902-67318252-7B30-4F5B-89FF-1D3B357912B3

Q36831902-CA775D65-FFE5-4955-8FE9-29679AE3E1D5

Q36831902-D15B99F2-EB67-4651-9DAE-B729F7816994

P2860

Q36831902-0CF3B01E-D156-4118-8889-5ED08C7C3B85

Q36831902-21944D94-F724-4F9A-BF45-8280DCF808A5

Q36831902-2F022B6D-ECBA-48E0-9896-7F1E3E3C7FB0

Q36831902-510E5B8E-C1D0-4A78-AA62-7B452C2F87F1

Q36831902-5A615191-C526-4D36-A610-52C60D429099

Q36831902-5D58B62A-77C5-4C08-8DA4-6A8963A33166

Q36831902-65156DDF-08C5-4821-AAA3-044DCA5B68B8

Q36831902-69A8761D-40BB-4906-AF1A-11ADC6817859

Q36831902-74F8D54C-4DD8-4559-AA05-4F966B06965F

Q36831902-860A2434-0F07-4BB0-A157-9765DC7F3C5C

P304

Q36831902-5E4F213A-B9BF-4D88-BCA8-5C91EEBC1C38

P31

Q36831902-84AE6ED1-79DF-42CA-811D-F189C5D7B67C

P356

Q36831902-1AA0A4D6-2CEF-4FB7-AC65-BFB56397528F

P433

Q36831902-4B5E260A-48A7-444E-ACD4-7BA8D75C5E41

P478

Q36831902-1615CEC1-AFB3-4ABE-B1FC-90CB10BF71E6

P50

Q36831902-8B19B89E-4994-44E9-84CF-9ACBD93D743F

P577

Q36831902-E852397A-97F1-46CB-BC7F-90664F7987E5

P698

Q36831902-EB5D7F55-DE76-43DA-AC0B-DF179B61E981

P932

Q36831902-131FE7C0-8BBC-4580-BF92-8E0E2ECD21E1

P356

P1433

P1476

The cost-effectiveness of plat ...... allergic transfusion reactions

@en

P2093

Aaron A R Tobian

http://www.w3.org/2001/XMLSchema#string

Jeffrey McCullough

http://www.w3.org/2001/XMLSchema#string

Karen E King

http://www.w3.org/2001/XMLSchema#string

Kevin D Frick

http://www.w3.org/2001/XMLSchema#string

Paul M Ness

http://www.w3.org/2001/XMLSchema#string

William J Savage

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction of the volume of stored platelet concentrates for use in neonatal patients.

An introduction to Markov modelling for economic evaluation.

Pharmaco-economics of blood transfusion safety: review of the available evidence.

Allergic transfusion reactions: an evaluation of 273 consecutive reactions.

Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes.

Febrile nonhemolytic transfusion reactions. Management by premedication and cost implications in adult patients.

The impact of apheresis platelet manipulation on corrected count increment

Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children.

Transfusion premedications: a growing practice not based on evidence.

Scratching the surface of allergic transfusion reactions.

P304

2609-2618

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.12095

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23363552

http://www.w3.org/2001/XMLSchema#string

P932

3650119

http://www.w3.org/2001/XMLSchema#string